Man Group plc - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 180 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$832,000
-57.3%
23,338
-44.8%
0.00%
-50.0%
Q2 2023$1,950,238
+141.7%
42,277
+110.1%
0.01%
+100.0%
Q1 2023$806,852
-54.4%
20,121
-47.3%
0.00%
-50.0%
Q4 2022$1,770,316
+24.1%
38,211
+11.0%
0.01%
-14.3%
Q3 2022$1,426,000
-8.6%
34,438
+31.6%
0.01%0.0%
Q2 2022$1,561,000
+219.9%
26,176
+289.3%
0.01%
+250.0%
Q1 2022$488,000
-74.2%
6,724
-59.6%
0.00%
-75.0%
Q1 2021$1,895,000
-69.7%
16,645
-63.1%
0.01%
-70.4%
Q4 2020$6,250,000
+133.3%
45,148
+38.5%
0.03%
+145.5%
Q3 2020$2,679,000
+19.9%
32,593
+14.1%
0.01%0.0%
Q2 2020$2,235,000
+34.7%
28,577
-23.5%
0.01%0.0%
Q1 2020$1,659,000
-59.6%
37,348
-61.2%
0.01%
-21.4%
Q4 2019$4,107,000
+87.0%
96,143
+87.2%
0.01%
+75.0%
Q3 2019$2,196,000
-48.8%
51,346
-24.0%
0.01%
-50.0%
Q2 2019$4,290,000
-20.4%
67,563
-13.1%
0.02%
-20.0%
Q1 2019$5,389,000
+188.0%
77,705
+80.5%
0.02%
+150.0%
Q4 2018$1,871,000
-50.4%
43,043
-12.8%
0.01%
-42.9%
Q3 2018$3,770,00049,3840.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2019
NameSharesValueWeighting ↓
Abingworth LLP 38,100$2,928,0001.67%
Opaleye Management Inc. 80,000$6,149,0001.59%
HIGHLINE CAPITAL MANAGEMENT, L.P. 410,000$31,517,0001.06%
Opus Point Partners Management, LLC 6,311$485,0001.05%
SECTOR GAMMA AS 68,015$5,228,0000.87%
Capital Impact Advisors, LLC 27,074$2,061,0000.76%
FORTALEZA ASSET MANAGEMENT INC/ 1,130$87,0000.71%
CAPITAL INTERNATIONAL LTD /CA/ 46,957$3,610,0000.63%
Virtus ETF Advisers LLC 8,794$676,0000.60%
Rock Springs Capital Management LP 200,000$15,374,0000.59%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders